Apyx Medical (APYX) Net Cash Flow (2011 - 2026)

Apyx Medical (APYX) has reported Net Cash Flow for 16 consecutive years, with -$3.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 141.75% year-over-year to -$3.6 million; the trailing twelve-month figure through Jun 2026 stood at -$1.4 million (up 55.35% YoY), and the FY2025 full-year result was $465000.0, up 103.87% from the prior year.
• Net Cash Flow fell to -$3.6 million in Q2 2026 per APYX's latest filing, from -$549000.0 in the prior quarter.
• Across five years, Net Cash Flow topped out at $21.5 million in Q4 2023 and bottomed at -$6.4 million in Q1 2024.
• Historically, Net Cash Flow has averaged -$171722.2 across 5 years, with a median of -$2.5 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Net Cash Flow sank 2882.17% in 2022, then soared 560.04% in 2023.
• Over 5 years, Net Cash Flow stood at -$4.7 million in 2022, then jumped by 560.04% to $21.5 million in 2023, then tumbled by 83.39% to $3.6 million in 2024, then surged by 86.7% to $6.7 million in 2025, then slumped by 153.31% to -$3.6 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$3.6 million, -$549000.0, and $6.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.